319
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

The effect of different rituximab-containing chemotherapy strategies on hepatitis C viremia

, , , &
Pages 1487-1490 | Received 12 Aug 2015, Accepted 19 Sep 2015, Published online: 16 Nov 2015
 

Acknowledgements

Presented in part at the 56th Annual Meeting of the American Society of Hematology, December 6–9, 2014, San Francisco, CA.

Potential conflict of interest

Harrys A. Torres is a consultant for Janssen Pharmaceuticals, Gilead Sciences, Merck & Co., Vertex Pharmaceuticals, Novartis, Genentech, Astellas, Pfizer, and Theravance and received research grants from Gilead Sciences, Merck & Co., and Vertex Pharmaceuticals. All other authors had no potential conflicts of interest to disclose. Disclosure forms provided by the authors are available with the full text of this article at http://dx.doi.org/10.3109/10428194.2015.1099649

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.